What Goes Around Comes Around!

Quote
















































The recruiting firm Chelsea hired is doing a fantastic job. Thia is evident by the rejects whining on cafe pharma with little background knowledge and a deep desire to know what the color choices are for company car.
 












Anonymous said:
The joke is on YOU!!!!! we just got approval, now go back to your 10 sigs a day and 3 lunches a week metrics , big pharma loser
Click to expand...

Not a true approval. The FDA still has to vote, so the drug isn't FDA approved. Understand the differences between a panel review suggestion for approval and a FDA approval. They don't decide until March 28th. They still could say no to the drug.
 






Anonymous said:
The joke is on YOU!!!!! we just got approval, now go back to your 10 sigs a day and 3 lunches a week metrics , big pharma loser
Click to expand...

It amazes me how dumb people make themselves look. Anyone who has half a brain realizes an fda ad panel does not equal approval. Are you sure you are not the big pharma loser yourself.

This drug has a very poor chance of approval. Read what the reviewers have said. Yes the panel voted yes but it wasn't overwhelming. The FDA has the final say and they are very cautious these days. I give it 25% chance of making it.

Sell the stock short and make some cash!
 






I give it about a 75 percent chance of approval with a significant post-marketing commitment and possible REMS. There are no other effective treatments out there for this orphan disease. The FDA won't go against the AC.
 












Anonymous said:
I give it about a 75 percent chance of approval with a significant post-marketing commitment and possible REMS. There are no other effective treatments out there for this orphan disease. The FDA won't go against the AC.
Click to expand...

Check out Dendreon from a few years ago. The board overwhelmingly voted yes on safety and efficacy.

The problem is Chelsea's data is all over the place and their 3rd study(306) also missed its interm efficacy numbers. Just don't get your hopes up

A REMS is a definate
 


















Anonymous said:
Check out Dendreon from a few years ago. The board overwhelmingly voted yes on safety and efficacy.

The problem is Chelsea's data is all over the place and their 3rd study(306) also missed its interm efficacy numbers. Just don't get your hopes up

A REMS is a definate
Click to expand...

You were right my friend! Or hold your hope for a couple of years
 






Chelsea Human Resources please read:

I personally believe what comes around goes around and was treated poorly in process of interviewing process. The manager was unprofessional, late, and clearly did not look at good candiates for job and discrimination came to mind too. In time of reviewing product with fda again I would also take time to review your selection for managers. There were several qualified people interested until they spoke to managers. In 14 years in industry I have never experienced such poor attitude, professionalism, and vocabulary during interview process and I wanted nothing with company reflecting on manager chosen in my area.
 






Ok, so if you truly believe what comes around goes around, how does all the negative comments you put onto others not come back to you one day. Did you even think that by all the negative wishes of this product and company not coming to market affect other people and their family? Did you think about those that were offered a job that have been looking for months and finally found hope in supporting their family were crushed when they heard the news? What comes around goes around right? Well then, one day you will feel the pain that some people felt when they realized they're back at square one. Lesson: don't wish bad onto others or one day you will be in their shoes. Just a thought.
 






Top Bottom
Back
Quote